Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Hanne, Nøkleby"'
Autor:
Lotta Siira, Hanne Nøkleby, Regine Barlinn, Øystein R. Riise, Ingeborg S. Aaberge, Susanne G. Dudman
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 10, Pp 2472-2477 (2018)
Limited data exist on the immunogenicity of a third dose of the measles, mumps, and rubella vaccine (MMR). In this study, our aim was to evaluate the long-term rubella immunogenicity afforded by two childhood MMR doses of the Norwegian vaccination pr
Externí odkaz:
https://doaj.org/article/e36f59840b3b4250835a5c46c2bee7a7
Autor:
Hanne, Nøkleby, Geir, Bukholm
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 139(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::803a9cf85dab6f266014b5dcb11f3269
https://pubmed.ncbi.nlm.nih.gov/31429238
https://pubmed.ncbi.nlm.nih.gov/31429238
Autor:
Hanne Nøkleby, Geir Bukholm
Publikováno v:
Tidsskrift for Den norske legeforening.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f61ca2ec20bc6c80dbf75952b039b4d4
https://doi.org/10.4045/tidsskr.19.0443
https://doi.org/10.4045/tidsskr.19.0443
Autor:
Berit Feiring, Ida Laake, Siri Seterelv, Hanne Nøkleby, Siri E. Håberg, Per Magnus, Lill Trogstad, Tor Molden
Publikováno v:
Vaccine. 34:2015-2020
Background Selective immunisation is an alternative to universal vaccination if children at increased risk of disease can be identified. Within the Norwegian Childhood Immunisation Programme, BCG vaccine against tuberculosis and vaccine against hepat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a295c820d172dedd28d4100f705bda5
https://doi.org/10.1016/j.vaccine.2016.02.060
https://doi.org/10.1016/j.vaccine.2016.02.060
Publikováno v:
The European respiratory journal. 53(1)
Low risk of tuberculosis in Norway prompts abandoning a policy of universal BCG vaccination of all health students and personnelhttp://ow.ly/2lYW30mIVRN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e1695eb3d60afa435138ce6e43df5cb
https://pubmed.ncbi.nlm.nih.gov/30630851
https://pubmed.ncbi.nlm.nih.gov/30630851
Autor:
Helvi Holm Samdal, Hanne Nøkleby, Regine Barlinn, Susanne Gjeruldsen Dudman, Kirsti Vainio, Svein Arne Nordbø
Publikováno v:
Journal of Medical Virology. 86:820-826
Infections caused by cytomegalovirus (CMV), parvovirus B19 (B19), and rubella can lead to serious complications in pregnant women. The aim of this study was to determine the susceptibility to CMV, B19, and rubella antibodies in pregnant women in Norw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59d0ae6becb0ff49d86a5e9a82ffa2e1
https://doi.org/10.1002/jmv.23757
https://doi.org/10.1002/jmv.23757
Autor:
Øystein Rolandsen, Riise, Ida, Laake, Marianne Adeleide Riise, Bergsaker, Hanne, Nøkleby, Inger Lise, Haugen, Jann, Storsæter
Publikováno v:
BMC Pediatrics
Background Delayed vaccinations increase the risk for vaccine preventable diseases (VPDs). Monitoring of delayed vaccinations by using a national immunisation registry has not been studied in countries recommending a two-dose (3 and 5 months of age)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d8a0bf4dd2c9413a84460e9517ef07ee
https://pubmed.ncbi.nlm.nih.gov/26563381
https://pubmed.ncbi.nlm.nih.gov/26563381
Autor:
Svein Hansen, Ling Yuan Hem, Jarle Norstein, Hanne Nøkleby, Bjørn Møller, Tom Grotmol, Guri Olsen Thu
Publikováno v:
International Journal of Cancer. 118:2035-2039
Between 1955 and 1963, an estimated number of 150 million people in various parts of the world, including Norway, received poliomyelitis vaccine possibly contaminated with infectious simian virus 40 (SV40). Human studies have investigated the hypothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e11b18718a57bdb78ebf4ca82fd34d2
https://doi.org/10.1002/ijc.21603
https://doi.org/10.1002/ijc.21603
Autor:
Philipp Oster, Ellen Ypma, Anne-Cathrine Kristoffersen, E. Arne Høiby, Ingeborg S. Aaberge, Berit Feiring, Oddveig S. Helland, Hanne Nøkleby
Publikováno v:
Clinical and Vaccine Immunology. 12:599-605
MenBvac and Menjugate are safe and efficacious vaccines. The purpose of this study was to evaluate safety and immunogenicity of the combination (MenB/C) of the lyophilized active components of the conjugated group C vaccine Menjugate when reconstitut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf714d10aa7950bb59a58ddee8f9e4d5
https://doi.org/10.1128/cdli.12.5.599-605.2005
https://doi.org/10.1128/cdli.12.5.599-605.2005
Autor:
David Fitzsimons, Guido François, Katharina Alpers, Doris Radun, Johannes Hallauer, Wolfgang Jilg, Wolfram Gerlich, Lars Rombo, Hans Blystad, Hanne Nøkleby, Pierre Van Damme
Publikováno v:
Scandinavian journal of infectious diseases
The Viral Hepatitis Prevention Board (VHPB) convened a meeting of international experts from the public and private sectors in the Nordic countries and Germany, in order to review the epidemiological situation, the surveillance systems for infectious
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::105870c903c68eee61efdf6fa8da46bc
https://doi.org/10.1080/00365540510043284
https://doi.org/10.1080/00365540510043284